» Articles » PMID: 16458357

The Current Status of Sheep Pox Disease

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Sheep are the moving banks of shepherds and their economic contribution in terms of meat, wool and skin/hide is immense. Various infectious diseases jeopardize the optimum productivity; among which sheep pox is more important as the disease restricts the export of sheep and their products besides other economic losses. Although, clinical signs are indicative of the disease but a laboratory confirmation is necessary for unequivocal diagnosis and studying epidemiology. The causative agent, sheep pox virus (SPV), is antigenically and genetically closely related to goat pox virus (GPV) and lumpy skin disease virus (LSDV), the other members of the genus capripox virus. In some countries, SPV and GPV are cross infective to small ruminants posing problem in diagnosis and epidemiology. However, recent studies have showed that the viruses are phylogenetically distinct and can be differentiated by molecular tools. Prophylaxis using attenuated vaccines is the choice of control measure as the immunity is long lasting. Detailed information on isolation, identification, pathology, epidemiology, diagnosis and prophylaxis would not only help in updating the knowledge of scientific fraternity but will be useful to the policy makers in order to formulate appropriate measures for control and eradication of the disease. This synthesis is to present an up-to-date review of the disease and its control to provide the reader with an overview of the problem.

Citing Articles

Progress in diagnostic methods and vaccines for lumpy skin disease virus: a path towards understanding the disease.

Farag T, Abou-Zeina H, Abdel-Shafy S, Allam A, Ghazy A Vet Res Commun. 2025; 49(3):134.

PMID: 40056298 PMC: 11890411. DOI: 10.1007/s11259-025-10667-2.


Development and validation of recombinant A27L based indirect-ELISA for Sheeppox and Goatpox disease in India.

Manjunatha Reddy G, Sudeep N, Apsana R, Sumana K, Sai Mounica P, Yogisharadhya R Vet Res Commun. 2025; 49(2):90.

PMID: 39869249 DOI: 10.1007/s11259-025-10656-5.


Promising antiviral inhibitors against lumpy skin disease: A vetinformatics approach.

Krishna S, Sarkar A, Banerjee S, Panja A Open Vet J. 2024; 14(11):2806-2816.

PMID: 39737031 PMC: 11682754. DOI: 10.5455/OVJ.2024.v14.i11.9.


Live attenuated goatpox vaccination in pregnant Murcia-Granada goats: dosage implications and outcomes.

Esmaeili H, Ghorani M, Joghataei S, Villanueva-Saz S, Lacasta D BMC Vet Res. 2024; 20(1):544.

PMID: 39623355 PMC: 11610293. DOI: 10.1186/s12917-024-04395-z.


Lumpy Skin Disease: Insights into Molecular Pathogenesis and Control Strategies.

Haider A, Abbas Z, Taqveem A, Ali A, Khurshid M, El Naggar R Vet Sci. 2024; 11(11).

PMID: 39591335 PMC: 11598853. DOI: 10.3390/vetsci11110561.